Evidence from a Comprehensive Bioinformatics Analysis Point to Possible Therapeutic Targets for Vitiligo

Yingwei Wang,1,* Tao Yao,2,* Yunlu Lin,2,* Jianming Wu1 1Department of Dermatology, The Second Affiliated Hospital and Yuying Children’s Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, 325000, People’s Republic of China; 2Department of Cardiology, The S...

Full description

Saved in:
Bibliographic Details
Main Authors: Wang Y, Yao T, Lin Y, Wu J
Format: Article
Language:English
Published: Dove Medical Press 2025-05-01
Series:Clinical, Cosmetic and Investigational Dermatology
Subjects:
Online Access:https://www.dovepress.com/evidence-from-a-comprehensive-bioinformatics-analysis-point-to-possibl-peer-reviewed-fulltext-article-CCID
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849425283288924160
author Wang Y
Yao T
Lin Y
Wu J
author_facet Wang Y
Yao T
Lin Y
Wu J
author_sort Wang Y
collection DOAJ
description Yingwei Wang,1,* Tao Yao,2,* Yunlu Lin,2,* Jianming Wu1 1Department of Dermatology, The Second Affiliated Hospital and Yuying Children’s Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, 325000, People’s Republic of China; 2Department of Cardiology, The Second Affiliated Hospital and Yuying Children’s Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, 325000, People’s Republic of China*These authors contributed equally to this workCorrespondence: Jianming Wu, Email wjm9515@163.comBackground: Vitiligo is an autoimmune, hypopigmented dermatological disease for which the pathogenesis remains unclear. With limited therapeutic options, it has a significant treatment burden and adverse psychological effects for patients.Methods: The core method employed was Mendelian randomization (MR), which was used to assess the impact of over 2,000 plasma proteins on generalized vitiligo. To further enhance the reliability of the MR conclusions, we conducted a series of comprehensive analyses, including reverse MR, the Steiger test, colocalization analysis, and phenotype scanning. Subsequently, we employed Phenome-wide MR (PheW-MR) analysis to exclude targets associated with adverse effects and evaluated the druggability of these targets through drug gene list mapping and molecular docking. Additionally, we employed protein-protein interaction (PPI) analysis to elucidate the interactions between the target proteins and existing vitiligo treatments. Finally, pathway enrichment analysis and transcriptome-proteome correlation analysis provided further biological insight into the target proteins.Results: Following a series of comprehensive analyses, we identified three potential drug targets for the treatment of vitiligo: GZMB, FCRL3, and ULK3, each of which is associated with an increased risk of the disease. Validation across different cohorts confirmed the significance of GZMB and FCRL3. Colocalization analysis indicated that these targets share common variants with vitiligo, while PheW-MR analysis suggested that targeting these proteins would not result in significant side effects. Furthermore, molecular docking demonstrated stable binding between the target proteins and predicted drugs. The PPI network revealed that GZMB, FCRL3, and ULK3 interact with the target proteins of existing vitiligo treatments.Conclusion: Our study has identified three promising drug target proteins for the treatment of vitiligo, which merit prioritization in drug development efforts. These targets warrant further investigation to elucidate their underlying mechanisms.Keywords: Mendelian randomization, vitiligo, drug target, protein quantitative trait loci, Bayesian colocalization, molecular docking
format Article
id doaj-art-dbec6807407d4cd5b110f38fd82bf7d2
institution Kabale University
issn 1178-7015
language English
publishDate 2025-05-01
publisher Dove Medical Press
record_format Article
series Clinical, Cosmetic and Investigational Dermatology
spelling doaj-art-dbec6807407d4cd5b110f38fd82bf7d22025-08-20T03:29:49ZengDove Medical PressClinical, Cosmetic and Investigational Dermatology1178-70152025-05-01Volume 18Issue 112811295103330Evidence from a Comprehensive Bioinformatics Analysis Point to Possible Therapeutic Targets for VitiligoWang Y0Yao T1Lin Y2Wu J3Department of DermatologyDepartment of CardiologyDepartment of CardiologyDepartment of DermatologyYingwei Wang,1,* Tao Yao,2,* Yunlu Lin,2,* Jianming Wu1 1Department of Dermatology, The Second Affiliated Hospital and Yuying Children’s Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, 325000, People’s Republic of China; 2Department of Cardiology, The Second Affiliated Hospital and Yuying Children’s Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, 325000, People’s Republic of China*These authors contributed equally to this workCorrespondence: Jianming Wu, Email wjm9515@163.comBackground: Vitiligo is an autoimmune, hypopigmented dermatological disease for which the pathogenesis remains unclear. With limited therapeutic options, it has a significant treatment burden and adverse psychological effects for patients.Methods: The core method employed was Mendelian randomization (MR), which was used to assess the impact of over 2,000 plasma proteins on generalized vitiligo. To further enhance the reliability of the MR conclusions, we conducted a series of comprehensive analyses, including reverse MR, the Steiger test, colocalization analysis, and phenotype scanning. Subsequently, we employed Phenome-wide MR (PheW-MR) analysis to exclude targets associated with adverse effects and evaluated the druggability of these targets through drug gene list mapping and molecular docking. Additionally, we employed protein-protein interaction (PPI) analysis to elucidate the interactions between the target proteins and existing vitiligo treatments. Finally, pathway enrichment analysis and transcriptome-proteome correlation analysis provided further biological insight into the target proteins.Results: Following a series of comprehensive analyses, we identified three potential drug targets for the treatment of vitiligo: GZMB, FCRL3, and ULK3, each of which is associated with an increased risk of the disease. Validation across different cohorts confirmed the significance of GZMB and FCRL3. Colocalization analysis indicated that these targets share common variants with vitiligo, while PheW-MR analysis suggested that targeting these proteins would not result in significant side effects. Furthermore, molecular docking demonstrated stable binding between the target proteins and predicted drugs. The PPI network revealed that GZMB, FCRL3, and ULK3 interact with the target proteins of existing vitiligo treatments.Conclusion: Our study has identified three promising drug target proteins for the treatment of vitiligo, which merit prioritization in drug development efforts. These targets warrant further investigation to elucidate their underlying mechanisms.Keywords: Mendelian randomization, vitiligo, drug target, protein quantitative trait loci, Bayesian colocalization, molecular dockinghttps://www.dovepress.com/evidence-from-a-comprehensive-bioinformatics-analysis-point-to-possibl-peer-reviewed-fulltext-article-CCIDMendelian randomizationvitiligodrug targetprotein quantitative trait lociBayesian colocalizationmolecular docking
spellingShingle Wang Y
Yao T
Lin Y
Wu J
Evidence from a Comprehensive Bioinformatics Analysis Point to Possible Therapeutic Targets for Vitiligo
Clinical, Cosmetic and Investigational Dermatology
Mendelian randomization
vitiligo
drug target
protein quantitative trait loci
Bayesian colocalization
molecular docking
title Evidence from a Comprehensive Bioinformatics Analysis Point to Possible Therapeutic Targets for Vitiligo
title_full Evidence from a Comprehensive Bioinformatics Analysis Point to Possible Therapeutic Targets for Vitiligo
title_fullStr Evidence from a Comprehensive Bioinformatics Analysis Point to Possible Therapeutic Targets for Vitiligo
title_full_unstemmed Evidence from a Comprehensive Bioinformatics Analysis Point to Possible Therapeutic Targets for Vitiligo
title_short Evidence from a Comprehensive Bioinformatics Analysis Point to Possible Therapeutic Targets for Vitiligo
title_sort evidence from a comprehensive bioinformatics analysis point to possible therapeutic targets for vitiligo
topic Mendelian randomization
vitiligo
drug target
protein quantitative trait loci
Bayesian colocalization
molecular docking
url https://www.dovepress.com/evidence-from-a-comprehensive-bioinformatics-analysis-point-to-possibl-peer-reviewed-fulltext-article-CCID
work_keys_str_mv AT wangy evidencefromacomprehensivebioinformaticsanalysispointtopossibletherapeutictargetsforvitiligo
AT yaot evidencefromacomprehensivebioinformaticsanalysispointtopossibletherapeutictargetsforvitiligo
AT liny evidencefromacomprehensivebioinformaticsanalysispointtopossibletherapeutictargetsforvitiligo
AT wuj evidencefromacomprehensivebioinformaticsanalysispointtopossibletherapeutictargetsforvitiligo